版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認(rèn)領(lǐng)
文檔簡介
Concepts-
1.Pharmacology
2.Pharmacodynamics
3.Pharmacokinetics
4.FirstPassElimination
5.Phase1and2ofmetabolism
6.Compartmentmodel
7.First-ordereliminationkinetics
8.Steady-stateconcentration
9.Halflife
10.Clearance
11.Bioavailability
12.Sidereaction
13.Toxicreaction
14.Residualeffect
15.Withdrawaleffect
16.Efficacy
17.Therapeuticindex
18.pD2
19.Noncompetitiveantagonist
20.Agonist-nonspecificdesensitization
1.Thelargestporesforaqueousdiffusionarefoundin:
a.capillarymembranes
b.pituitarygland
c.renalglomeruli
d.intestinallumen
2.Highlyionizeddrugstendtoaccumulateinthe:
a.brain
b.fattissue
c.heart
d.urine
3.apatientisgiven600mgofacertaindrugintravenouslyandthe
extrapolatedplasmaconcentrationattimezerois12mg/1.Whatisthe
apparentvolumeofdistribution?
a.201
b.501
c.961
d.1121
4.Theeliminationconstantforaparticulardrugis0.231/min.What
isthehalf-life?
a.2min
b.3min
c.4min
d.5min
5.alkalizationoftheurineenhancestherecoveryfrom
phentobarbitalpoisoning.ThismeansthatPhenobarbitalmustbe:
a.aweakbase
b.aweakacid
c.astrongacid
d.astrongbase
6.whichofthefollowingstatementisnottrue?
a.lipidsolubilitydeceasesrenalexcretion
b.alkalinizationofurinewillincreaseexcretionofweakbase
c.additionofbicarbonatewilldecreasereabsorptionofaweakacid
d.excretionisenhancedbyincreasingpolarity
7.whichofthefollowingisfalse?
a.drugsboundtoproteincanbesecreatedbutnotfilteredbythe
kidneys
b.drugsthatinhibittubularsecretionofanotherdrugwillprolong
thehalf-lifeofthelatterdrug
c.increasingthepHoftheurinewillincreaserenalaxcretionofa
weakacid
d.increasingthepHoftheurinewillincreasetheamountofdrug(a
base)intheionizedform
8.themainsiteofdrugmetabolismisthe
a.liver
b.redbloodcell
c.smallintestine
d.kidney
9.theoxidativemetabolismofmanydrugsismediatedbyenzymes
locatedinthe:
a.mitochondrialfraction
b.lysosomalfraction
c.cellmembranes
d.microsomalfraction
10.whichcytochromeP450isasignificantfactorcontributingto
thepoororalbioavailabilityofmanydrug?
a.CYP3A
b.CYP2D
c.CYP1A2
d.CYP2E1
11.theprimeryalternativetoexcretionofdrugsintheurineis
drugexcretionin:
a.sweat
b.bile
c.milk
d.tears
12.whichprocessisquantitativelythemostsignificantinleading
toaccumulationofacidicorbasicdrugsintheurine?
a.tubularsecreton
b.glomarularfiltration
c.failureofreabsorption
d.pinocytosis
13.whichofthefollowingfactornotlimitsthedrugsfromentering
theCNS:
a.capillariesinthebrainarelesspereabletodrugs
b.capillariesinthebrainaresurroundedbywrappingofglial
cells
c.theCSFisrelativelyvoidofprotein
d.thebrainhasarelativelylowbloodflow
14.theenterohepaticcycledoesnotincludes:
monbileduct
b.superiormesentericvein
c.hepaticartery
d.portalvein
15.whichisnotcorrectforcAMP:
videsenergyforenzymereactionswhichproducebiological
responses
b.isformedbyactivatedadenylylcyclase
c.isactivatedbyphosphodiesterase
d.activatesintracellularproteinkinase
16.steroidscan'tcontrolmetabolicratesby:
a.effectingnuclearchromatin
b.enhancingtranscriptionofmRNA
c.bindingcytoplasmicrecptorproteins
d.stimulationofsecondmessengerpathway
17.themaximaleffectproducedbyadrugisreferredtoasits:
a.potency
b.antagonisticactivity
c.efficacy
d.affinity
18.non-competitiveantagonists:
a.decreasetheapparentaffinityoftheagonistforthereceptors
b.decreasethetotalnumberofeffictivereceptors
c.maybeovercomebyhighdosesoftheagonist
d.increasethemaximaleffectobtainedwithagonist
19.afterdailyadministrationofdrugsat5daysatthesame
dose,theexpectedresponsetothedrugismarkedlydecreasedbecausethe
physiologicstoresofeffectedendogenouscomponentaredepleted.Thisis
anexampleof:
a..metabolictolerance
b.tachyphylaxis
petitvetolerance
d.drugaccumulation
20.themajoradverseeffectofcyclophosphamide,whenusedtotreat
Hodgkin'sdisease,couldbeclassifiedas:
a.desiredexcessiveeffects
b.directedtowardsthehemopoieticsystem
c.drugidiosyncrasy
d.doesindependent
21.whichofthefollowingadverseeffectscouldnotbeconsiderdas
anoverextensionofthepharmacologicalactionsofthedrug?
a.diazepam(valium)induceddrowsiness
b.cyclophosphamideinducedhemopoieticcuppression
c.atropineinduceddrymouth
d.acetaminophen(Tylenol)inducedlivertoxicity
22.whichofthefollowingadverseeffectscouldbeclassifiedas
organdirected:
a.morphineinducednephrotoxicity
b.methotrexateinducedlivertoxicity
c.epinephrineinducedrespiratorydepression
d.aminoglycosideinducedarrhythmias
23.whichofthefollowingadverseeffectsarelikelytobemediated
byTYPEIimmunologicmechanism?
a.penicillininducedshock
b.chymotrypsininducedanaphylaxis
c.primaquineinducedhemolyticanemia
d.cholramphenicolinducedaplasticanemia
24.whichofthefollowingisnotamediatorforanaphylactic
response
a.acetylcholine
b.histamine
staglandins
d.slowreactingsubstanceA(SRSA,leukotrieneC
25.Whichofthefollowingadverseeffectsarelikelytobemediated
byaTYPEIIimmunologicalmechanism?
a.quinidineinducedthrombocytopenia
b.methlydopainducedautoimmunehemolyticanemia
c.penicillininducedhemolyticanemia
d.alloftheabove
26.whichofthefollowingadverseeffectsisnotlikelytobe
mediatedbyTYPEIIIimmunologicmechanism?
a.sulfonamideinducedserumsickness
b.penicillininducedanaphylaxis
c.penicillininducedserumsickness
d.tetanusantitoxininducedserumsickness
27.whichofthefollowingdrugsallergiescantbeclassifiedasa
TYPEIVorDELAYEDHYPERSENSITIVITYresponse?
a.sulfonamideinducedcontactdermatitis
b.poisonivyinducedcontactdermatitis
c.penicillininducedcontactdermatitis
d.sulfonamideinducedagranulocytosis
28.whichofthefollowingacutehemolyticanemiaswouldmostlikely
notbemediatedbyanimmunologicalmechanism?
a.penicillininducedacutehemolyticanemia
b.sufonamideinducedacutehemolyticanemiainaCaucasiangirl
c.alpha-methlydopainducedautoimmunehemolyticanemia
d.sulfonamideinducedacutehemolyticanemiainaBlackmale
29.whichofthefollowingstatementsaretrueregardingtheeffects
ofdrugsonthefetus?
a.adruggivenearlyinpregnancymaycausefetaldeath
b.adruggivenduringpregnancyorganogenesisismostlikelyto
causephysicalmalformations
c.adruggivenlateinpregnancyorduringlabormaycausefetal
morbidityordeath
d.alloftheabove
30.whichofthefollowingagentsisbestrecognizedasaclassical
exampleofadrugwhichcausesteratogenesis?
a.penicillin
b.aspirin
c.diazepam
d.thalidomide
31.whichofthefollowingisnotanexampleofiatrogenicdisease?
A.chroramphenicolinducedaplasticanemia
b.ethanolinducedhepatocellulardisease
c.atropineinduceddrymouth
d.aminoglycosideinducedglomerularnephritis
32.A19yearoldwomanwhoisallergictosulfadrugswasgivenco-
trimoxazoletotreatanaerobicGram-negativeinfectioncausedby
Moraxellacatarrhalis.whichisthemostcommonmanifestationofallergic
responsetoasulfadrugsuchassulfamethoxazolecontainedinco-
trimoxazole?
a.dizziness
b.jaundice
c.lossofhair
d.pruritis
e..vomiting
33.A21yearoldmanisdiagnosedwithNeisseriameningitides.A
disadvantageofgivingPENICILLINGbytheoralroutetothepatientis:
a.absorptionthedrugisverygood
b.expenseoftheoralformulation
c.extentofabsorptionisoftenuncertain
d.penicillinGishighlytoxictothegastricmucosa
34.A45yearoldmanisonmultipledrugtherapy.Whichofthe
followingdrugsismostlikelytoinducemicrosomalenzymes?
a.cimetidine
b.erythromycin
c.ketoconazole
d.phenytoin
35.A59yearoldmanwiththromboembolicdiseaseisbeingtreated
withwarfarin.Whichstatementistrueregardingthesteady-state
concentrationofdrugssuchaswarfarin?
a.fluctuationsarebluntedbyslowabsorption
b.plateaulevelisdirectlyproportionaltovolumeofdistribution
c.steady-stateconcentrationsareusuallyachievedmorerapidlyin
geriatricpatients
d.steady-stateconcentrationsaredirectlyrelatedtoclearance
36.Mostbiologicaleffectsofthiscompoundoccurafteralag
periodof30mins,toseveralhours:
a.acetycholine
b.hydrocortisone
c.insulin
d.nitreoxide(NO)
37.Thereceptorsformostpharmacodynamicagents(excluding
chemotherapeuticagents)arebelievedtoresideinwhichcellular
structure?
a.cytoplasm
b.lysosomes
c.surfacemembrane
d.nucleus
e.mitochondria
38.A49-yearoldmanwithcardiovasculardiseaseisspendingone
yearinamalariainfestedarea.Heistalkingseveraldrugsand
developsanimmunologicalmediatedadverseeffects.Whichdrugismost
likelyresponsibleforanimmunologicalmediatedadverseeffects?
a.alpha-methyldopainducedacutehemolyticanemia
b.atropineinduceddrymouth
c.diazepaminducedsedation
d.primaquineinducedacutehemolyticanemia
39.anewbornchildhasmoderateCrigler-Najjarsyndrometype
II.Thepartialdeficiencyofhepaticmicrosomalenzymeglucuronyl
transferaseactivityinthischildmaycause:
a.adecreaseinserumunconjugatedbilirubinlevels
b.anincreaseintheexcretionofunconjugatedbilirubininbileand
urine
c.increasedclearanceofacetaminophen
d.unresponsivnesstoinductionbyPhenobarbitaltreatment
40.A13yearoldgirl'sseizuredisorderiscontrolledby
phenobarbitaltherapy.WhichPhasellreactionisknowntobeinducedby
Phenobarbital?
a.acetylationreactions
b.gluconideconjugation
c.methylationreactions
d.sulfateconjugation
41.Whichofthefollowingstatementsistrueregardingdrug
metabolism?
a.conjugationreactionsalwaysincreasesthewatersolubilityofa
drug
b.esterlinkagesareusuallymorerapidlyhydrolyzedthanamide
linkages
c.glucuronidesarenevereliminatedbysecretioninurineorbile
d.sterichindrancearoundafunctionalgroupincreasestheratesof
metabolism
42.An18yearoldisbeingadvisedbyherobstetricianaboutthe
effectsofdrugsonthefetus.Afactorthatcontributestothe
protectionofthefetusfromadverseeffectsofadrugis:
a.acompletebarriertodrugpassagebytheplacenta
b.highlipidsolubilityofthedrug
c.metabolismofthedrugbytheplacenta
d.veryrapiddrugmetabolismbythefetus
43.Anemanciated25yearoldmanwithHIVisbeingtreatedwith
severaldrugs.Therateofpassivediffusionofdrugmoleculesthrough
biologicalmembranesinthispatientisgreaterforcompoundswhichare:
a.insolubleinaqueoussolutions
b.ionized
c.largerinmolecularsize
d.morelipidsoluble
44.Thetherapeuticindexis:
a.bettertherapeutically,atavalueof2thanat10
b.determinedfromgradeddose-responsecurves
c.themedianlethaldosedividedbythemedian-response
d.usedtodeterminetherelativepotencyoftwodrugs
45.A40yearoldmanistakingoralerythromycinforthetreatment
ofLegionnaire,sdisease.Whichfactorwillcontributemostto
absorptionvariabilityday-to-dayinthispatient?
a.dailybileoutput
b.dailyurineoutput
c.metabolismintheliver
d.timethedrugistakenwithrespecttomeals
46.Whichcharacteristicistruefortheactivetransportbutnot
forthefacilitateddiffusionofadrugacrossbiologicalmembranes?
a.exhibitssaturabilityathighdrugconcentrations
b.requiresmetabolicenergy
c.siteofdrug-druginteraction
d.showsstereospecificity
47.Weaklyacidicdrugssuchasbarbituratesorsalicylates:
a.aresolelyabsorbedinthestomach
b.haveareducedrateofrenalexcretionduringmetabolicor
respiratoryacidosis
c.haveincreasedplasmaproteinbindingduringsevereinflammation
d.mustbemetabolizedpiortoenteringthebrain
48.Whichdrugisprobablythemostsafetousein33-year-oldwoman
whoisinherfirsttrimesterofpregnancy?
a.cyclophosphamide
b.folicacid
c.isotretinion
d.thalidomide
49.Nitroglycerinisanorganicnitrateusedinthemanagementof
anginapectoris.Itisconvertedtonitricoxide(NO),areactivefree
radical,whichisknowntoactivate:
a.adenylylcyclase
b.beta-arrestin
c.guanylylcyclase
d.phospholipaseC
50.Therenalclearanceofadrugisfavoredifthedrug:
a.hasahighdegreeofbindingtoplasmaprotein
b.hashighlipidsolubility
c.hashighwatersolubility
d.isacetylated
51.Whichproteinservesasanimportantplasmabindingsitefor
somedrugsthatareweakorganicbasesanditsconcentrationinplasma
increasesduringacuteinflammation?
a.aibumin
b.immunoglobulin
c.orosomucoid
d.steroidbindinghormone
52.Whichagentismostfavoredforexcretioninacidurine(pH
4)comparedtoalkalineurine(pH8)?
a.acetylsalicylic(acid,pKa3.5)
b.codeine(base,pKa7.9)
c.diazepam(base,pKa3.3)
d.phenytoin(acid,pKa8.3)
53.Theplasmahalf-lifeofsalicylateincreasesastheoraldoseof
sodiumsalicylateIincreasedbecauseof:
a.adecreaseinthefractionabsorbedfromGItract
b.alimitedcapacityforbiotransformationofsalicylate
c.alimitedcapacityforexcretionofsalicylate
d.decreasedvolumeofdistributionofsalicylate
54.Afirst-orderdeclineindrugconcentrationinthebloodmeans
that:
a.aconstantamountofdrugiseliminatedeachhour
b.drugconcentrationplottedagainsttimeisastraightline
c.logdrugconcentrationversustimeplotgivesastraightline
d.thebiologicalsystemissaturated
55.Clearanceofdrugsbywhichprocessmaybeenhancedbyplasma
proteinbinding:
a.biliarysecretion
b.exhalation
c.gastrointestinaldiffusion
d.livermetabolism
56.A4-yearoldboyisgivenchloramphenicolforthetreatmentof
bacterialmeningitis.Theglucuronideconjugateofchloramphenicolis:
a.formedfromtheinactiveintermediateglucuronylCoA
b.knowtocauseaplasticanemia
c.pharmacologicallyactive
d.predominantlyintheionizedformatphysiologicalpH
57.Drugglucuronideswhichundergoenterohepaticrecirculation
couldbeexpectedtobeeliminatedmorerapidlythannormalina
patoientwith:
a.congestiveheartfailure
b.diminishedintestinalflorafromantibiotictherapy
c.gastrointestinalrefluxdisease
d.hypertension
58.Theactionsofwhichofthefollowingismediatedviageneration
ofcyclicAMP
a.acetylcholine(m1-muscarinicreceptors)
b.glucagons
c.hydrocortisone
d.insulin
59.A21-yearoldpatientwithdiabetesmellitustypeIisbeing
treatedwithinsulinwhichexertsitsactionviaa(n):
a.cyclicAMPsignal
b.1igand-regulatedproteintyrosinekinase
c.nitricoxidesignal
d.polyphosphoinositidesignal
60.Whichofthefollowingagentsexertsitsactionviathe
synthesisofspecificproteinsthroughenhancedgeneexpression?
a.acetylcholine
b.isoproterenol
c.verapamil
d.vitaminD
61.A96-yearoldwomanwhoisbeingtreatedwithseveraldrug
experiencesanintensifiedresponsetooneofthedrugs.Thiseffectis
unlikelyrelatedtoadecreasein:
a.albumin
b.bloodflow
c.gastricpH
d.kidneyfunction
62.Whichofthefollowingtermsdescribesadrugthatbindstoa
receptorbutdoesnotproduceanydirectpharmacologicalresponse?
a.agonist
b.antagonist
c.inverseagonist
d.partialagonist
63.Whichofty=hefollowingpharmacologicalagentsexertsthe
statedresponseviaasurfaceboundreceptor?
a.antiproliferationeffectsofmethotrexate
b.bactericidaleffectsofpenicillin
c.bacteriostaticeffectsofsulfonamides
d.isoproterenolinducedcardiacacceleration
64.A67-yearoldmandevelopedacutehemolyticanemiaafterbeing
treatedforhypertensionwithmethyldopa.Methyldopa-inducedacute
hemolyticanemiaisconsideredtobemediatedbya(n):
a.enzymedeficiency
b.typeIhypersensitivityreaction
c.typeIIhypersensitivityreaction
d.typeIIIhypersensitivityreaction
65.Whichofthefollowingmodesofmembranepassageisresponsible
forthebiliaryexcretionofdrugs?
a.activetransport
b.facilitateddiffusion
c.filtration
d.pinocytosis
66.Decreasedresponsestosuccessiveequaldosesofadruggivento
atestsubjectduring
ashortperiodoftimeismostaccuratelydefinedas:
a.anaphylaxis
b.antagonism
c.supersensitivity
d.tachyphylaxis
67.Whichofthefollowingisagoodindicatorofsafetyfora
therapeuticagent?
a.hightherapeuticindex
b.lowpotency
c.lowtherapeuticindex
d.rapidmetabolism
68.Whichofthefollowingdruglinkedmechanismislikely
responsibleforatypeIIIallergicreactionina31-yearoldmanwhois
beingtreatedforTrepanomapallidum?
a.penicillin-inducedacutehemolyticanemia
b.penicillin-inducedanaphylaxis
c.penicillin-inducedcontactsensitivity
d.penicillin-inducedserumsickness
69.Whichofthefollowingisthebestexampleofpharmacokinetic
tolerance?
a.decreasedanticoagulanteffectofwarfarininepilepticstreated
withphenytoin
b.naloxonereversalofmorphineinducedrespiratorydepression
c.reducedsedationwithdailybenzodiazepinetreatment
d.staphycoccalresistancetopenicillin
70.plasmaproteinbindingofdrugs:
a.decreasesthedoserequired
b.decreasesthehalf-lifeofthedrug
c.decreasesvolumeofdistribution
d.increaseingeriatricpatients
71.Whichofthefollowingadverseeffectsisconsideredtobean
idiosyncraticreaction?
a.atropineinduceddrymouth
b.isoniazid-inducedseizures
c.methyldopa-inducedhemolyticanemia
d?primaquine-inducedacut
ehemolyticanemia
72.Growthfactorsandinsulinexerttheirsignalingeefectsvia:
a.calciumchannels
b.G-proteins
c.phosphatases
teintyrosinekinases
73.A36-yearoldwomanisbeingtreatedforaurinarytract
infection(UTI).Whatclassofmetabolitesantimicrobialdrugsismost
likelytoprecipitateintubularurine?
a.acetylationconjugates
b.glucuronides
c.glutathioneconjugates
d.glycineconjugates
74.Whichofthefollowingdrugsmediatetheirpharmacological
responsesviaintracellularreceptorsthatregulategeneexpression?
a.beta-blockers
b.calciumchannelblockers
c.corticosteriods
d.penicillins
75.Whichofthefollowingagentsisadministeredbyinjectionfor
treatmentofsystemicinfections?
A.Doxycycline
B.Gentamicin
C.Isoniazid
D.Linezolid
76.Whichofthefollowingdrugswillreadilypenetratetheblood-
brainbarriermakingthemusefulintreatinginfectionsofCNS?
A.Ampicillin,Sulfadiazine
B.Gentamicin,Sulfadiazine
C.Gentamicin,Chloramphenicol
D.Sulfadiazine,Chloramphenicol
77.Whichofthefollowingdrugscanbegiventopatientswithrenal
dysfunctionatthesamemaintencedosethatisusedinpatientswith
normalrenalfunction?
A.Chloramphenicol,Streptomycin
B.Erythromycin,Chloramphenicol
C.Streptomycin,Gentamicin
D.Erythromycin,Gentamicin
78.Whichofthefollowingagentshavesystemicactionsterminated
primarilybyglomerularfiltration?
A.Streptomycin,Penicillin
B.Erythromycin,Penicillin
C.Tetracyclines,Streptomycin
D.Erythromycin,Tetracyclines
79.Renalexcretionisslowedbyconcomitantadministrationof
probenecid:
A.Penicillin
B.Aminoglycosides
C.Both
D.Neither
80.Dosemustbeadjustedinpatientswithrenalfailure:
A.Gentamicin,Tetracycline
B.Chloramphenicol,Clindamycin
C.Tetramycine,Gentamycin
D.Clindamycin,Gentamicin
81.Inactivatedbyacetylation:
A.Suladiazine,Chloramphenicol
B.Isoniazid,Sulfadiazine
C.Gentamicin,Isoniazid
D.Chioramphenico1,Gentamicin
82.A43-year-oldmanwithstaphylococcalsepticemiawhoisallergic
toampicillinandcephalothinandwhoseorganismsareresistantto
erythromycincouldbetratedwith:
A.Cefixime
B.Vancomycin
C.Tetracycline
D.Clarithromycin
83.Whichofthefollowingdrugshasthebestchemotherapeuticindex?
A.Ampicillin
B.Ciprofloxac
C.Cyclophosphamide
D.Amikacin
84.A36-year-oldmanhasacquiredaninfectionthatwasfoundtobe
resistanttoanantibioticbecauseofareplacementofterminalD-Alaby
D-lactateatthedrug-bindingsite.Thisbacteriawillberesistantto
whichofthefollowingdrugs?
A.Ciprofloxacin
B.Erythromycin
C.Vancomycin
D.PenicillinG
85.Sulfonamides(mainmechanismbywhichsystemicactionis
terminated):
a.acidificationoftheurine
b.glomerularfiltration
c.metabolismintheliver
d.secretionofbile
86.Competitiveinhibitionisthoughttobethemechanismbywhich
procaineinterfereswithchemotherapeuticeffectof
a.ampicillin
b.chloramphenicol
c.sulfamethoxazole
d.ciprofloxacin
87.Whichofthefollowingagentswould
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 行政總廚個人述職報告
- 糖尿病護理方案
- 3.3.1鹽類的水解酸堿性高二上學(xué)期化學(xué)人教版(2019)選擇性必修1
- 足跟痛的診斷與治療
- 保護牙齒小班安全教案反思
- 荷塘月色說課稿
- 安踏企業(yè)五年戰(zhàn)略規(guī)劃
- 生物物理學(xué)實驗室安全操作
- 機場租賃合同
- 健身中心土地租賃協(xié)議
- 肯布蘭佳領(lǐng)導(dǎo)力發(fā)展戰(zhàn)略課程
- 26個標(biāo)點符號大全
- GB/T 9115.1-2000平面、突面對焊鋼制管法蘭
- GB/T 7322-2017耐火材料耐火度試驗方法
- GB/T 30790.2-2014色漆和清漆防護涂料體系對鋼結(jié)構(gòu)的防腐蝕保護第2部分:環(huán)境分類
- GB/T 19811-2005在定義堆肥化中試條件下塑料材料崩解程度的測定
- 第5課 文化變革 美術(shù)發(fā)展 課件 【高效課堂+備課精研】 高一美術(shù)魯美版美術(shù)鑒賞
- pep 三年級英語課本人物介紹PPT課
- 2023年北京清華附中小升初考試數(shù)學(xué)真題及答案
- 希沃優(yōu)化大師操作培訓(xùn)
- 氧氣吸入法(課堂)課件
評論
0/150
提交評論